NDC 51662-1334
PROCAINAMIDE HCI
Procainamide Hci
PROCAINAMIDE HCI is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Procainamide Hydrochloride.
Product ID | 51662-1334_8192d79d-da2c-2532-e053-2991aa0ae8ad |
NDC | 51662-1334 |
Product Type | Human Prescription Drug |
Proprietary Name | PROCAINAMIDE HCI |
Generic Name | Procainamide Hci |
Dosage Form | Injection, Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2019-02-10 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA089069 |
Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
Substance Name | PROCAINAMIDE HYDROCHLORIDE |
Active Ingredient Strength | 100 mg/mL |
Pharm Classes | Antiarrhythmic [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |